Agian
Well-known member
dick0236;n877926 said:LondonAndy.....are you confusing Crestor with Coumadin?
Not a good idea LMAO
dick0236;n877926 said:LondonAndy.....are you confusing Crestor with Coumadin?
Biological Vs Mechanical Valves – Key Points
|
mikeccolella;n877946 said:In response to Pellicle's inquiry the following is an excerpt from the study cited and Which swayed me to choose a tissue valve at 63. It should be noted the advantage swings over to the mechanical valve after 10 years. It is also notable what they conclude wrt careful monitoring.
mikeccolella;n877946 said:[TD]Biological Vs Mechanical Valves – Key Points
- Long-term survival is equivalent
- Mid-term morbidity is worse with mechanical valves
- Reoperation rates are low with biological valves and are not insignificant with mechanical valves
- Reoperative aortic valve replacement has similar mortality to primary valve replacement
- Complications of mechanical prosthesis are more devastating than those of biological valves
- Mechanical valves can have substantial negative impact on daily quality of lif
dick0236;n877926 said:LondonAndy.....are you confusing Crestor with Coumadin? In the US Crestor is a statin.
I would suggest you look to testing weekly, not monthly. Why? Well if you are out when you test you don't knowmick1807;n877951 said:.... Take a tablet a day, get a test a month seems fine.
mikeccolella;n877946 said:In response to Pellicle's inquiry the following is an excerpt from the study cited and Which swayed me to choose a tissue valve at 63. It should be noted the advantage swings over to the mechanical valve after 10 years. It is also notable what they conclude wrt careful monitoring.
"In contrast, mechanical valves are associated with a reoperation rate of 0.6% per year, bleeding rate of about 1.5% per year and thromboembolism rate of 0.6% per year[SUP]4[/SUP] – in a young patient this amounts to over 20% risk of major complication in the first decade post valve replacement. Several approaches to improved anticoagulation, such as use of novel anticoagulants, home International Normalized Ratio (INR) testing, and lower INR targets have not transformed to reduction in morbidity with mechanical valves[SUP]7, 8[/SUP]. In one recent trial a bleeding rate of 3.3% per year was noted in patients receiving conventional anticoagulation[SUP]9"
the above is from the first page section 2
Superman;n877960 said:So this is the study itself that is suggesting annual statistics are cumulative? Seems odd. Or am I misreading?
dick0236;n877964 said:No Superman, this argument of a cumulative risk is wrong.
dick0236;n877964 said:No Superman, this argument of a cumulative risk is wrong. Each year is an independent risk from the earlier years and each event(.6% reop, 1.5% bleed, .6% clot) is independent from the others. It's like flipping a coin, or three coins......the chance of a "head" on the first flip is 50%/coin and the chance of a "head" on the tenth flip is 50%/coin.......,so your risk of one of these heart events happening in the first year is .6%, 1.5%, .6%, not 2.7%.....and the risk at the end of the first decade remains(might change a little due to other factors) .6%, 1.5%, .6%.....not 2.7% x 10years = 27%
There is an older post done by a professor at Notre Dame (I think) who did a very good statistical presentation explaining the cumulative fallacy of this type of argument. He also noted that his pre-med students where notoriously poor at Statistics.....LOL.
Now, if you will excuse me, I need to lie down as my current risk is 2.7%++ x 50 = 135%+++.......so I gotta be very careful........:Tongue:
agreed ... however when I did my masters by research we were EXPECTED to undertake critical analysis of EVERY journal article we cited. It was part of our lit review process.mikeccolella;n877970 said:Hey the article says what it says. Their conclusions are what they are. Take 'em or leave 'em. .
mikeccolella;n877978 said:Pellicle, it bugs me that we have to even discuss these things.
But there probably IS no clear picture. The choices are ultimately an individual thing.
jcgtok17;n877904 said:Doug, Tough call. I recently went with a tissue valve (St. Jude Medical 28mm GT model). The AVR (BAV) operation was 5/1/17 and mechanical was not given much consideration in Japan, where I had the procedure, despite my age (50). Crown is a popular valve in Japan (average 22mm). I read that in Germany 70% of value replacements are now tissue values. I'm comfortable with my choice (no Warfarin) and recovery is going very well. I take Crestor and recent studies show use (statins) extends the life of tissue valves. Best of luck with both your decision and the operation/recovery. JCG
Enter your email address to join: